Skip to content

13F-HR filed by INVESTOR AB

INVESTOR AB filed this 13F-HR for the quarter ended 2026-03-31, filed 2026-05-15, with 10 holding rows worth $15,124,585,250.

Accession
0001493152-26-023718
Filed
2026-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2026

A holdings report, 10 entries on the cover page, a total value of $15,124,585,250 stated on the cover page (in dollars after the unit check, H1), rows summing to $15,124,585,250 with VALUE read as dollars as filed, 13F file number 028-03431. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ASTRAZENECA PLC ORDG0593M107ADR51,587,810$10,174,147,888dollars as filed
NASDAQ INC COM631103108Stock58,382,426$4,932,731,173dollars as filed
MEDIWOUND LTDM68830112COMMON STOCK872,093$14,049,418dollars as filed
CELLEBRITE DI LTD ORDINARY SHARESM2197Q107Stock55,000$757,900dollars as filed
COHERENT CORP COM19247G107Stock3,000$714,630dollars as filed
KYIVSTAR GROUP LTDG5331N101ORD SHS59,402$601,148dollars as filed
Verizon Communications Inc92343V104COM11,300$567,260dollars as filed
CORSAIR GAMING INC22041X102COM99,711$553,396dollars as filed
WHIRLPOOL CORP COM963320106Stock4,700$253,424dollars as filed
BIOMARIN PHARMACEUTICAL INC09061G101COM3,700$209,013dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001493152-26-023718this filing2026-05-15acceptance time not in the bulk data set